Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Biol Inorg Chem ; 23(8): 1227-1241, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30145655

RESUMEN

With the increasing life expectancy of the world's population, neurodegenerative diseases, such as Alzheimer's disease (AD), will become a much more relevant public health issue. This fact, coupled with the lack of efficacy of the available treatments, has been driving research directed to the development of new drugs for this pathology. Metal-protein attenuating compounds (MPACs) constitute a promising class of agents with potential application on the treatment of neurodegenerative diseases, such as AD. Currently, most MPACs are based on 8-hydroxyquinoline. Recently, our research group has described the hybrid aroylhydrazone containing the 8-hydroxyquinoline group INHHQ as a promising MPAC. By studying the known structure-related ligand HPCIH, which does not contain the phenol moiety, as a simplified chemical model for INHHQ, we aimed to clarify the real impact of the aroylhydrazone group for the MPAC activity of a compound with potential anti-Alzheimer's activity. The present work describes a detailed solution and solid-state study of the coordination of HPCIH with Zn2+ ions, as well as its in vitro binding-ability towards this metal in the presence of the Aß(1-40) peptide. Similar to INHHQ, HPCIH is able to efficiently compete with Aß(1-40) for Zn2+ ions, performing as expected for an MPAC. The similarity between the behaviors of both ligands is remarkable. Taken together, the data presented herein point to aroylhydrazones, such as the compounds HPCIH and the previously published INHHQ, as encouraging MPACs for the treatment of AD.


Asunto(s)
Hidrazonas/química , Nootrópicos/química , Piridinas/química , Zinc/química , Enfermedad de Alzheimer/tratamiento farmacológico , Péptidos beta-Amiloides/metabolismo , Complejos de Coordinación/síntesis química , Complejos de Coordinación/química , Complejos de Coordinación/metabolismo , Hidrazonas/síntesis química , Hidrazonas/metabolismo , Ligandos , Estructura Molecular , Nootrópicos/síntesis química , Nootrópicos/metabolismo , Fragmentos de Péptidos/metabolismo , Prueba de Estudio Conceptual , Unión Proteica , Piridinas/síntesis química , Piridinas/metabolismo , Zinc/metabolismo
2.
J Pharm Sci ; 107(2): 672-681, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29031975

RESUMEN

A new monohydrated polymorph of dexamethasone acetate was crystallized and its crystal structure characterized. The different analytical techniques used for describing its structural and vibrational properties were: single crystal and polycrystal X-ray diffraction, solid state nuclear magnetic resonance, infrared spectroscopy. A Hirshfeld surface analysis was carried out through self-arrangement cemented by H-bonds observed in this new polymorph. This new polymorph form appeared because of self-arrangement via classical hydrogen bonds around the water molecule.


Asunto(s)
Dexametasona/análogos & derivados , Cristalización/métodos , Cristalografía por Rayos X/métodos , Dexametasona/química , Enlace de Hidrógeno , Espectroscopía de Resonancia Magnética/métodos , Agua/química , Difracción de Rayos X/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA